Filing Flows › Cytek Biosciences (CTKB) › Service revenue
Cytek Biosciences (CTKB) Service revenue by quarter
Cytek Biosciences' Service revenue was $16.1M in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $13.3M (Q1 2025) to $16.1M (Q3 2026).
| Quarter | Service revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.1M | +3% | +13% |
| Q2 2026 | $15.6M | +1% | +10% |
| Q1 2026 | $15.4M | -1% | +15% |
| Q4 2025 | $15.5M | +10% | — |
| Q3 2025 | $14.2M | -0.1% | — |
| Q2 2025 | $14.2M | +6% | — |
| Q1 2025 | $13.3M | — | — |
Q3 2026 at a glance
Cytek Biosciences, Q3 2026: revenue $53.2M (+2% year over year), operating margin -15.8%, net loss $6.1M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cytek Biosciences' Service revenue?
Cytek Biosciences' Service revenue was $16.1M in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Cytek Biosciences' Service revenue changed?
Over the last 7 quarters it ranged from $13.3M (Q1 2025) to $16.1M (Q3 2026).